Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota

NCT05285449 is registered in ClinicalTrials.gov with Christopher Bell as lead sponsor.

NCT NCT05285449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05285449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota
Lead sponsor
Christopher Bell
Phase
Not applicable
Overall status
Completed
Start date
February 9, 2022
Completion date
May 31, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes